XMHQ vs. FPHAX

Last updated Jun 9, 2026

XMHQ (Invesco S&P MidCap Quality ETF) and FPHAX (Fidelity Select Pharmaceuticals Portfolio) are both funds - XMHQ is a Mid Cap Blend Equities fund tracking the S&P MidCap 400 Index, while FPHAX is a Health & Biotech Equities fund managed by Fidelity. Over the past 10 years, XMHQ returned 12.56%/yr vs 11.73%/yr for FPHAX. A 0.56 correlation means they provide meaningful diversification when combined. XMHQ charges 0.25%/yr vs 0.75%/yr for FPHAX.

Performance

XMHQ vs. FPHAX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Invesco S&P MidCap Quality ETF (XMHQ) and Fidelity Select Pharmaceuticals Portfolio (FPHAX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, XMHQ achieves a 7.58% return, which is significantly lower than FPHAX's 10.17% return. Over the past 10 years, XMHQ has outperformed FPHAX with an annualized return of 12.56%, while FPHAX has yielded a comparatively lower 11.73% annualized return.

XMHQ

• 1D: -0.34%
• 1M: 0.12%
• YTD: 7.58%
• 6M: 8.05%
• 1Y: 12.57%
• 3Y*: 15.37%
• 5Y*: 9.12%
• 10Y*: 12.56%

FPHAX

• 1D: -0.78%
• 1M: 6.37%
• YTD: 10.17%
• 6M: 11.79%
• 1Y: 40.05%
• 3Y*: 17.98%
• 5Y*: 13.47%
• 10Y*: 11.73%

*Multi-year figures are annualized to reflect compound growth (CAGR)

XMHQ vs. FPHAX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
XMHQ Invesco S&P MidCap Quality ETF	7.58%	4.71%	16.79%	29.51%	-12.42%	20.98%	26.61%	27.18%	-9.08%	15.64%
FPHAX Fidelity Select Pharmaceuticals Portfolio	10.17%	30.41%	9.39%	12.54%	0.94%	11.79%	11.16%	31.73%	5.41%	10.70%

Correlation

The correlation between XMHQ and FPHAX is 0.45, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.45
Correlation (3Y) Calculated over the trailing 3-year period	0.48
Correlation (5Y) Calculated over the trailing 5-year period	0.49
Correlation (10Y) Calculated over the trailing 10-year period	0.49
Correlation (All Time) Calculated using the full available price history since Dec 4, 2006	0.56

The correlation between XMHQ and FPHAX shifts across timeframes, from 0.45 (1 year) to 0.56 (all time), reflecting how their relationship changes across market environments.

Return for Risk

XMHQ vs. FPHAX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

XMHQ

XMHQ Risk / Return Rank: 27
XMHQ Sharpe Ratio Rank: 25
XMHQ Sortino Ratio Rank: 25
XMHQ Omega Ratio Rank: 23
XMHQ Calmar Ratio Rank: 32
XMHQ Martin Ratio Rank: 31

FPHAX

FPHAX Risk / Return Rank: 59
FPHAX Sharpe Ratio Rank: 54
FPHAX Sortino Ratio Rank: 53
FPHAX Omega Ratio Rank: 46
FPHAX Calmar Ratio Rank: 87
FPHAX Martin Ratio Rank: 55

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

XMHQ vs. FPHAX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Invesco S&P MidCap Quality ETF (XMHQ) and Fidelity Select Pharmaceuticals Portfolio (FPHAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	XMHQ	FPHAX	Difference
Sharpe ratio: Return per unit of total volatility	0.81	2.08	-1.27
Sortino ratio: Return per unit of downside risk	1.29	2.92	-1.64
Omega ratio: Gain probability vs. loss probability	1.15	1.35	-0.21
Calmar ratio: Return relative to maximum drawdown	1.43	4.09	-2.67
Martin ratio: Return relative to average drawdown	4.17	10.66	-6.49
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

XMHQ vs. FPHAX - Sharpe Ratio Comparison

The current XMHQ Sharpe Ratio is 0.81, which is lower than the FPHAX Sharpe Ratio of 2.08. The chart below compares the historical Sharpe Ratios of XMHQ and FPHAX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	XMHQ	FPHAX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.81	2.08	-1.27
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.44	0.75	-0.31
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.61	0.66	-0.05
Sharpe Ratio (All Time) Calculated using the full available price history	0.45	0.55	-0.10

Drawdowns

XMHQ vs. FPHAX - Drawdown Comparison

The maximum XMHQ drawdown since its inception was -58.19%, which is greater than FPHAX's maximum drawdown of -38.26%. Use the drawdown chart below to compare losses from any high point for XMHQ and FPHAX.

Drawdown Indicators

	XMHQ	FPHAX	Difference
Max Drawdown Largest peak-to-trough decline	-58.19%	-38.26%	-19.93%
Max Drawdown (1Y) Largest decline over 1 year	-8.85%	-10.33%	+1.48%
Max Drawdown (3Y) Largest decline over 3 years	-24.56%	-28.82%	+4.26%
Max Drawdown (5Y) Largest decline over 5 years	-25.47%	-28.82%	+3.35%
Max Drawdown (10Y) Largest decline over 10 years	-36.90%	-28.82%	-8.08%
Current Drawdown Current decline from peak	-2.44%	-0.78%	-1.66%
Average Drawdown Average peak-to-trough decline	-9.28%	-9.17%	-0.11%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.02%	3.96%	-0.94%

Volatility

XMHQ vs. FPHAX - Volatility Comparison

The current volatility for Invesco S&P MidCap Quality ETF (XMHQ) is 4.06%, while Fidelity Select Pharmaceuticals Portfolio (FPHAX) has a volatility of 5.71%. This indicates that XMHQ experiences smaller price fluctuations and is considered to be less risky than FPHAX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	XMHQ	FPHAX	Difference
Volatility (1M) Calculated over the trailing 1-month period	4.06%	5.71%	-1.65%
Volatility (6M) Calculated over the trailing 6-month period	11.28%	14.25%	-2.97%
Volatility (1Y) Calculated over the trailing 1-year period	15.61%	20.30%	-4.69%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	20.76%	18.07%	+2.69%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	20.72%	17.88%	+2.84%

XMHQ vs. FPHAX - Expense Ratio Comparison

XMHQ has a 0.25% expense ratio, which is lower than FPHAX's 0.75% expense ratio.

Dividends

XMHQ vs. FPHAX - Dividend Comparison

XMHQ's dividend yield for the trailing twelve months is around 0.56%, less than FPHAX's 5.05% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
FPHAX Fidelity Select Pharmaceuticals Portfolio	5.05%	5.68%	1.90%	8.08%	5.18%	11.09%	8.85%	8.33%	1.65%	1.62%	1.07%	12.63%
XMHQ Invesco S&P MidCap Quality ETF	0.56%	0.64%	5.20%	0.73%	1.72%	1.00%	1.12%	1.22%	1.59%	1.06%	1.63%	1.34%

Frequently Asked Questions

Can I hold both XMHQ and FPHAX in my portfolio?

XMHQ and FPHAX have a correlation of 0.45, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, XMHQ or FPHAX?

FPHAX has higher volatility (5.71%) compared to XMHQ (4.06%). In terms of maximum drawdown, XMHQ dropped -58.19% vs FPHAX's -38.26%.

Which has better risk-adjusted returns?

FPHAX currently has the higher Sharpe Ratio (2.08 vs 0.81), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.